Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
3 studies found for:    11910344 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Study of Terlipressin Versus Placebo to Treat Hepatorenal Syndrome Type 1
Condition: Hepatorenal Syndrome
Intervention: Drug: terlipressin
2 Active, not recruiting Terlipressin in Cirrhotic Patients With Recidivation Ascites Treated With Paracentesis and Albumin
Condition: Cirrhosis
Interventions: Drug: Terlipressin;   Drug: Placebo
3 Enrolling by invitation Study to Evaluate if the Drug Vasopressin Protects the Kidneys for Patients Undergoing Liver Transplant
Condition: Liver Failure
Interventions: Drug: Vasopressin;   Drug: Normal saline placebo

Indicates status has not been verified in more than two years